RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Medpace Holdings Net Income 2024

Medpace Holdings Net Income

335.27 M USD

Medpace Holdings Dividend yield

Ticker

MEDP

ISIN

US58506Q1094

WKN

A2APTV

In 2024, Medpace Holdings's profit amounted to 335.27 M USD, a 18.63% increase from the 282.62 M USD profit recorded in the previous year.

The Medpace Holdings Net Income history

YEARNET INCOME (undefined USD)
2029e689.19
2028e611.45
2027e540.99
2026e471.02
2025e400.86
2024e335.27
2023282.62
2022245.2
2021181.4
2020144.9
2019100.2
201872.9
201739
201613.4
2015-8.7
2014-15.6
201324.8

Medpace Holdings Aktienanalyse

What does Medpace Holdings do?

The company Medpace Holdings Inc is a global company specializing in conducting clinical trials and providing R&D services in the pharmaceutical and biotech industry. Medpace was founded in 1992 by Dr. August Troendle and is headquartered in Cincinnati, Ohio. Medpace's business model is based on offering a variety of services to pharmaceutical and biotech companies as a contract research organization (CRO), ranging from planning and conducting clinical trials to their evaluation. This includes regulatory consulting services, project management and data management, as well as monitoring and quality assurance. Medpace specializes in conducting complex studies for testing and approval of new drugs or medical technology products. However, the company also has experience in conducting post-marketing studies and supporting products that are already established in the global markets. Medpace's various divisions cover a wide range of therapy areas, from oncology and cardiovascular diseases to rare diseases and infectious diseases. The company has worked in over 60 countries and has 35 offices worldwide, including in Europe, Asia, and South America. Medpace has earned a reputation as a trusted partner in the planning, conducting, and evaluation of clinical trials and works closely with clients to understand their needs and requirements. The company has extensive experience working with regulatory authorities around the world and supports its clients in compliance with applicable regulations and requirements. Medpace's product portfolio includes a wide range of services tailored to the individual needs of its clients. These include: - Clinical trial management: Medpace supports clients in all aspects of planning, conducting, and monitoring clinical trials, including budget, personnel, and resource management. - Data management: Medpace offers comprehensive data management solutions, including data capture, validation, and storage, as well as a web-based platform for real-time data retrieval. - Regulatory consulting: Medpace provides support in all aspects of regulatory requirements, from preparation and submission of regulatory applications to monitoring and maintaining approvals. - Medical monitoring: Medpace provides experienced medical personnel to monitor the safety of study participants and assist in the monitoring of adverse events and interpretation of medical data. - Quality management: Medpace has a comprehensive quality management system that ensures all clinical trials are conducted according to the highest quality standards. Over the years, Medpace has received numerous awards and recognitions and is valued by its clients for its high quality, flexibility, and innovation. The company is constantly striving to improve its services and processes to meet the changing needs of the industry. Medpace Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Medpace Holdings's Profit Margins

The profit margins of Medpace Holdings represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Medpace Holdings's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Medpace Holdings's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Medpace Holdings's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Medpace Holdings’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Medpace Holdings Stock

How much profit has Medpace Holdings made this year?

Medpace Holdings has made 335.27 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 18.63% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Medpace Holdings publish its earnings?

Medpace Holdings publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Medpace Holdings?

The profits of Medpace Holdings are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Medpace Holdings?

You can learn more about the earnings of Medpace Holdings by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Medpace Holdings pay?

Over the past 12 months, Medpace Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medpace Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Medpace Holdings?

The current dividend yield of Medpace Holdings is .

When does Medpace Holdings pay dividends?

Medpace Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medpace Holdings?

Medpace Holdings paid dividends every year for the past 0 years.

What is the dividend of Medpace Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medpace Holdings located?

Medpace Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medpace Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medpace Holdings from 5/23/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/23/2024.

When did Medpace Holdings pay the last dividend?

The last dividend was paid out on 5/23/2024.

What was the dividend of Medpace Holdings in the year 2023?

In the year 2023, Medpace Holdings distributed 0 USD as dividends.

In which currency does Medpace Holdings pay out the dividend?

The dividends of Medpace Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medpace Holdings

Our stock analysis for Medpace Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medpace Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.